Diagnosis of resistance to chloroquine by Plasmodium vivax: Timing of recurrence and whole blood chloroquine levels

American Journal of Tropical Medicine and Hygiene

Volumn 56, Issue 6, 1997, Pages 621-626

  Baird, J Kevin ^a   Leksana, Budi ^b   Masbar, Sofyan ^b   Fryauff, David J ^b   Sutanihardja, M Awaludin ^b   Suradi, ^b   Wignall, F Stephen ^b   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DEETHYLCHLOROQUINE; QUININE;

ANTIMALARIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; PLASMODIUM VIVAX; RELAPSE;

CINCHONA PUBESCENS; PLASMODIUM VIVAX;

EID: 0030877592     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1997.56.621     Document Type: Article

References (34)

1. Rieckmann KH, Davis DR, Halton DC, 1989. Plasmodium vivax resistance to chloroquine? Lancet ii: 1183-1184.
2. Baird JK, Basri H, Purnomo, Bangs MJ, Subianto B, Patchen L, Hoffman SL, 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 44: 547-552.
3. Schwartz IK, Lackritz EM, Patchen LC, 1991. Chloroquine-resistant Plasmodium vivax from Indonesia (letter). N Engl J Med 324: 927.
4. Murphy GS, Basri H, Purnomo, Andersen EM, Bangs MJ, Mount DL, Gorden J, Lal AA, Purwokusumo AR, Harjosuwamo S, Sorensen K, Hoffman SL, 1993. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341: 96-100.
5. Baird JK, Basri H, Subianto B, Fryauff DJ, McElroy PD, Leksana B, Richie TL, Masbar S, Wignall FS, Hoffman SL, 1995. Treatment of chloroquine resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis 171: 1678-1682.
6. Than M, Kyaw MP, Soe AY, Gyi KK, Sabai M, Oo M, 1995. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans R Soc Trop Med Hyg 89: 307-308.
7. Coatney GR, 1963. Pitfalls in a discovery: the chronicle of chloroquine. Am J Trop Med Hyg 12: 121-128.
8. Wiselogle FY, 1946. A Survey of Antimalarial Drugs: 1941-1945. Two volumes. Ann Arbor, MI: J. W. Edwards.
9. Most H, London IM, Kane CA, Lavietes PH, Schroeder EF, Hayman JM Jr, 1946. Chloroquine for treatment of acute attacks of vivax malaria. JAMA 131: 963-967.
10. Craige B Jr, Alving AS, Jones R Jr, Whorton CM, Dullman TN, Eichelberger L, 1947. The Chesson strain of Plasmodium vivax malaria. II. Relationship between prepatent period, latent period and relapse rate. J Infect Dis 80: 228-236.
11. Gordon HH, Dieuadie TR, Marble A, Christianson HB, Dahl LK, 1947. Treatment of Plasmodium vivax malaria of foreign origin: a comparison of various drugs. Arch Intern Med 79: 365-379.
12. Pullman TN, Craige B Jr, Alving AS, Whorton CM, Jones R Jr, Eichelberger L, 1948. Comparison of chloroquine, quinacrine, and quinine in the treatment of acute attacks of sporozoite-induced vivax malaria (Chesson strain). J Clin Invest 27: 46-50.
13. Alving AS, Craige B Jr, Jones R Jr, Whorton CM, Pullman TN, Eichelberger L, 1948. Pentaquine, a therapeutic agent effective in reducing the relapse rate in vivax malaria. J Clin Invest 27 (suppl 2): 25-33.
14. Coatney CR, Cooper WC, Young MD, 1950. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J Natl Malaria Soc 9: 381-396.
15. Whorton CM, Yount E Jr, Jones R Jr, Alving AS, Pullman TN, Craige B Jr, Eichelberger L, 1950. Studies in human malaria. The Chesson strain of Plasmodium vivax malaria. III. Clinical aspects. J Infect Dis 80: 237-249.
16. Ehrman FC, Ellis JM, Young MD, 1945. Plasmodium vivax Chesson strain. Science 101: 377.
17. Patchen LC, Mount DL, Schwartz IK, Churchill FC, 1983. Analysis of filter paper absorbed, fingerstick blood samples for chloroquine and its major metabolite using high performance liquid chromatography with fluorescence detection. J Chromatogr 278: 81-89.
18. Jones TR, Baird JK, Bangs MJ, Annis BA, Purnomo, Basri H, Gunawan S, Harjosuwarno S, McElroy PD, Hoffman SL, 1994. Malaria vaccine study site in Irian Jaya, Indonesia: Plasmodium falciparum incidence measurements, epidemiologic considerations in sample size estimation. Am J Trop Med Hyg 50: 210-218.
19. Wernsdorfer WH, Payne D, 1988. Drug sensitivity tests in malaria parasites. Wernsdorfer WH, McGregor I, eds. Malaria. Edinburgh: Churchill Livingstone, 1770.
20. Pukrittayakamee S, Vanijanonta S, Chantra A, Clemens R, White NJ, 1994. Blood-stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis 169: 547-552.
21. Berliner RW, Earle DP Jr, Taggart JV, Zubrod CG, Welch WJ, Conan NJ, Bauman E, Scudder ST, Shannon JA, 1948. Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline. J Clin Invest 27: 98-107.
22. Brodie BB, Udenfriend S, Dill W, Downing G, 1947. The estimation of basic organic compounds in biological material. II. Estimation of fluorescent compounds. J Biol Chem 168: 319-325.
23. McChesney EW, Banks WF Jr, McAuliff JP, 1962. Laboratory studies of the 4-aminoquinoline antimalarials: II. Plasma levels of chloroquine and hydroxychloroquine in man after various oral dosage regimens. Antibiot Chemother 12: 583-594.
24. Black RH, Canfield CJ, Clyde DF, Peters W, Wernsdorfer WH, 1981. Chemotherapy of malaria. Second edition. Chapter 3. Bruce-Chwatt LJ, ed. Geneva: World Health Organization Monograph Series No. 27.
25. Rossan RN, Young MD, Baerg DC, 1975. Chemotherapy of Plasmodium vivax in Saimiri and Aotus models. Am J Trop Med Hyg 24: 168-173.
26. Schmidt LH, 1978. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). II. Responses to chloroquine, quinine and pyrimethamine. Am J Trop Med Hyg 27: 703-717.
27. Rombo L, Ericsson O, Alvan G, Lindstroem B, Gustafsson LL, Sjoeqvist F, 1985. Chloroquine and desethylchloroquine in plasma, serum and whole blood: problems in assay and handling of samples. Ther Drug Monit 7: 211-215.
28. Bergqvist Y, Domeij-Nyberg B, 1983. Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr 272: 137-148.
29. Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B, 1984. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol 26: 521-530.
30. Gustafsson LL, Rombo L, Alvan G, Bjorkman A, Lind M, Walker O, 1983. On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther 34: 383-385.
31. Akintonwa A, Meyer MC, Hwang PTR, 1983. Simultaneous determination of chloroquine and desethylchloroquine in blood plasma, and urine by high performance liquid chromatography. J Liq Chromatog 6: 1513-1522.
32. Verdier F Clavieer F, Deloron P, Blayo MC, 1984. Distribution de la chloroquine et de la, desethyl-chloroquine dans le sang, le plasma et les erythrocytes de sujets sains et paludeens. Dosage en HFLC. Pathol Biol (Paris) 32: 359-361.
33. Rombo L, Bjoerkman A, Sego E, Ericsson O, 1986. Whole blood concentrations of chloroquine and desethylchloroquine during and after treatment of adult patients infected with Plasmodium vivax, Plasmodium ovale, or Plasmodium malariae. Trans R Soc Trop Med Hyg 80: 763-766.
34. Rombo L, Bergqvist Y, Hellgren U, 1987. Chloroquine and desethylchloroquine concentrations during regular long-term malaria prophylaxis. Bull World Health Organ 65: 879-883.